-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UsNqGnl7mYOPsSnbL+rs1qNpWyaPYsD+jcaPdIq3TCPtzuDoKXpV55tHuh8I6Vhx R0wXbQTO9cBrAFQqMGnCcA== 0000914317-96-000280.txt : 19960816 0000914317-96-000280.hdr.sgml : 19960816 ACCESSION NUMBER: 0000914317-96-000280 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19960807 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 19960815 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNIGENE LABORATORIES INC CENTRAL INDEX KEY: 0000352747 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 222328609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16005 FILM NUMBER: 96616288 BUSINESS ADDRESS: STREET 1: 110 LITTLE FALLS RD CITY: FAIRFIELD STATE: NJ ZIP: 07004-2193 BUSINESS PHONE: 2018820860 MAIL ADDRESS: STREET 1: 110 LITTLE FALLS RD CITY: FAIRFIELD STATE: NJ ZIP: 07004-2193 8-K 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 7, 1996 UNIGENE LABORATORIES, INC. ------------------------------------------------------ (Exact name of registrant as specified in its charter) Delaware ---------------------------------------------- (State or other jurisdiction of incorporation) 0-16005 22-2328609 - ------------------------ ------------------------------------ (Commission File Number) (IRS Employer Identification Number) 110 Little Falls Road Fairfield, New Jersey 07004 --------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) (201) 882-0860 ---------------------------------------------------- (Registrant's telephone number, including area code) Item 5. Other Events. On August 7, 1996, the Company extended the expiration date of its Class B Warrants from August 11, 1996 to September 10, 1996. Item 7. Financial Statements and Exhibits. (c) Exhibits. 28 Press Release dated August 7, 1996 regarding extension of Class B Warrants. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. UNIGENE LABORATORIES, INC. By S/RONALD S. LEVY Ronald S. Levy, Vice President Date: August 13, 1996 EX-28 2 FOR IMMEDIATE RELEASE Contact: William Steinhauer, Controller Unigene Laboratories, Inc. (201) 882-0860 UNIGENE LABORATORIES EXTENDS CLASS B WARRANT EXPIRATION DATE Fairfield, NJ, August 7, 1996 -- Unigene Laboratories, Inc. (Nasdaq:UGNE) today announced that it is extending the expiration date of its Class B Warrants (Nasdaq:UGNEZ) by 30 days to September 10, 1996. Each Class B Warrant is currently exercisable at $3.504 for 1.4269 shares of Common Stock. Unigene Laboratories, Inc. has developed a proprietary amidation process capable of producing peptide hormones for the treatment of a variety of diseases and disorders including osteoporosis, hypertension and arthritis. -----END PRIVACY-ENHANCED MESSAGE-----